ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Karolinska Development's portfolio company Modus Therapeutics has successfully dosed first cohort in phase 1 study of subcutaneously administered sevuparin
February 24, 2019Karolinska Development's portfolio company Modus Therapeutics announces today that the first cohort has been successfully dosed in its phase 1 study to explore the pharmacokinetics, safety and tolerability of subcutaneous sevuparin injections in healthy a
Pharma Sources Insight January 2025
